Keysight Technologies, Inc. (KEYS) shares soared in pre-market trading after the company announced robust results for its third quarter. Keysight’s strong performance, exceeding analysts’ expectations, fueled optimism among investors. The company projected earnings between $1.53 and $1.59 per share for the fourth quarter, surpassing the estimated $1.54. Revenue is expected to fall within a range of $1.245 billion to $1.265 billion, slightly above the anticipated $1.25 billion. This positive outlook sent Keysight shares skyrocketing by 11.1% to $154.01 in pre-market trading.
Beyond Keysight’s impressive performance, other stocks saw notable movements in pre-market trading. Revelation Biosciences, Inc. (REVB) surged by a remarkable 170.1% to $2.81, following a strong performance on Tuesday. Anew Medical, Inc. (WENA) gained 68% to $1.73, boosted by its recent acquisition of a license for a Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke. Galmed Pharmaceuticals Ltd. (GLMD) witnessed a 44.8% increase to $0.4373. BigBear.ai Holdings, Inc. (BBAI) rose 33.1% to $1.76 after securing an award as a subcontractor to Concept Solutions. Sintx Technologies, Inc. (SINT) rebounded from Tuesday’s decline, gaining 28.2% to $5.54. Oblong, Inc. (OBLG) climbed 25.3% to $0.1338, reversing its Tuesday dip. Gaxos.ai Inc. (GXAI) continued its positive momentum from Tuesday, adding 21.1% to $3.04. Azitra, Inc. (AZTR) saw a 15.3% rise to $0.7330, driven by the commencement of its Phase 1b clinical trial evaluating ATR-12 for Netherton syndrome treatment. Invivyd Inc (IVVD) shares gained 14.7% to $0.99.
On the other side of the spectrum, several companies experienced pre-market declines. Eyenovia, Inc. (EYEN) shares plummeted by 34.1% to $0.4480 after the company announced a proposed public offering. Santech Holdings Limited (STEC) dropped 33.6% to $0.2850, reversing Tuesday’s significant jump. Aadi Bioscience, Inc. (AADI) declined 27.2% to $1.18 following the release of PRECISION1 trial and corporate updates. Mynaric AG (MYNA) fell 24.6% to $1.38, extending Tuesday’s substantial drop due to a revised FY24 revenue guidance. Applied DNA Sciences, Inc. (APDN) fell 24.1% to $1.17, continuing its downward trend from Tuesday. InMed Pharmaceuticals Inc. (INM) dropped 23.2% to $0.3310 after Tuesday’s surge. Treasure Global Inc. (TGL) decreased 17.8% to $1.15, following Tuesday’s significant gain. Heramba Electric plc (PITA) shares dipped 16.4% to $2.33 after a Tuesday jump. Allbirds Inc (BIRD) declined 16.2% to $0.61. Allego N.V. (ALLG) shares fell 7.8% to $1.77 after experiencing a substantial rise on Tuesday.
